Leukemia Research Reports: Volume 13 to Volume 14

Journal Spotlight: Leukemia Research Reports (LRR)

Leukemia Research Reports (LRR), a noteworthy sister publication to Leukemia Research, stands as an esteemed platform dedicated to the expedited dissemination of concise, high-quality papers related to a comprehensive range of topics in hematology. Here’s a glimpse into the essence and objectives of this distinguished journal:

Areas of Focus:

• Diverse Therapeutic Areas: LRR casts a wide net over the realm of hematology, covering both malignant and non-malignant diseases. Areas of emphasis include:
  • Hematopoetic and stem cell transplantation.
  • Marrow and stem cell reconstitution.
  • Leukemic hemopoiesis and its diverse manifestations.
  • An array of hematological malignancies such as leukemias, lymphomas, and multiple myelomas.
  • Cutting-edge cell-based therapies and cancer treatments, along with innovative immunotherapy approaches for hematological malignancy.

Objective and Impact:

• Guidance for Clinicians: LRR seeks manuscripts that impart direction to clinicians globally, underscoring best practices and illuminating groundbreaking clinical research in hematology.
• Pioneering Translational Science: The journal is enthusiastic about publishing content that details avant-garde translational science pertinent to hematological malignancies.
• Novel Observations: LRR welcomes findings that substantially enhance previously reported novel observations in the field.
• Clinical Principles: Through its content, the journal aims to spotlight crucial clinical principles pivotal to the care and management of patients with hematological conditions.
• Stimulating Scientific Discourse: LRR encourages contributions that invigorate scientific discussions from unique or unconventional standpoints.

Review and Accessibility:

• Peer Review Process: All submissions to LRR undergo rigorous peer review, ensuring the upholding of the journal’s standard of excellence.
• Indexing and Citations: Every article in LRR is indexed in renowned databases like PubMed/PubMed Central and Scopus. This indexing facilitates broad accessibility and ensures that each article is easily citable through its specific digital object identifier (DOI).
• Rapid Online Availability: Through ScienceDirect, a leading online content platform, LRR ensures that its research findings are promptly accessible to a global audience.

For researchers, clinicians, and scholars in the realm of hematology, Leukemia Research Reports serves as a crucial conduit for disseminating seminal work, pioneering observations, and invaluable clinical insights. If you have further inquiries or require additional details regarding this journal or related topics, please don’t hesitate to reach out.

Volume 13: 2020

Volume 14: 2020